Clinical trial
Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell…
NCT00156858 · Alberta Health services, Other · Unknown status
Key facts
| NCT number | NCT00156858 |
|---|---|
| Title | Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study |
| Official title | Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell |
| Lead sponsor | Alberta Health services, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Hematologic Malignancy |
| Intervention type | Drug |
| Interventions | intravenous busulfan |
| Enrollment | 200 |
| Start date | Jan 1, 1998 |
| Completion | Dec 1, 2010 |
| First posted | Sep 12, 2005 |
| Last update posted | Jan 19, 2012 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: